{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:15:27Z","timestamp":1789607727738,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Increasing detections of vaccine-derived poliovirus (VDPV) globally, including in countries previously declared polio free, is a public health emergency of international concern. Individuals with primary immunodeficiency (PID) can excrete polioviruses for prolonged periods, which could act as a source of cryptic transmission of viruses with potential to cause neurological disease. Here, we report on the detection of immunodeficiency-associated VDPVs (iVDPV) from two asymptomatic male PID children in the UK in 2019. The first child cleared poliovirus with increased doses of intravenous immunoglobulin, the second child following haematopoetic stem cell transplantation. We perform genetic and phenotypic characterisation of the infecting strains, demonstrating intra-host evolution and a neurovirulent phenotype in transgenic mice. Our findings highlight a pressing need to strengthen polio surveillance. Systematic collection of stool from asymptomatic PID patients who are at high risk for poliovirus excretion could improve the ability to detect and contain iVDPVs.<\/jats:p>","DOI":"10.1038\/s41467-023-39094-0","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T12:02:43Z","timestamp":1686312163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Asymptomatic immunodeficiency-associated vaccine-derived poliovirus infections in two UK children"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2572-0173","authenticated-orcid":false,"given":"Anika","family":"Singanayagam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra","family":"Klapsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirelle","family":"Burton-Fanning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Hand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Wilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Mate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4407-5998","authenticated-orcid":false,"given":"Benjamin","family":"Shillitoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2223-5057","authenticated-orcid":false,"given":"Cristina","family":"Celma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Slatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Flood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Gopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5326-7081","authenticated-orcid":false,"given":"Javier","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Zambon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,9]]},"reference":[{"key":"39094_CR1","unstructured":"World Health Organisation (WHO). Statement of the thirty third Polio IHR Emergency Committee. https:\/\/www.who.int\/news\/item\/01-11-2022-statement-of-the-thirty-third-polio-ihr-emergency-committee (2022)."},{"key":"39094_CR2","doi-asserted-by":"crossref","unstructured":"Klapsa, D. et al. Sustained detection of type 2 poliovirus in London sewage between February and July, 2022, by enhanced environmental surveillance. Lancet. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673622018049 (2022).","DOI":"10.1016\/S0140-6736(22)01804-9"},{"key":"39094_CR3","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1111\/ajt.16677","volume":"22","author":"R Link\u2010Gelles","year":"2022","unstructured":"Link\u2010Gelles, R. et al. Public health response to a case of paralytic poliomyelitis in an unvaccinated person and detection of poliovirus in wastewater\u2014New York, June\u2013August 2022. Am. J. Transplant. 22, 2470\u20132474 (2022).","journal-title":"Am. J. Transplant."},{"key":"39094_CR4","unstructured":"World Health Organisation (WHO). Detection of circulating vaccine derived polio virus 2 (cVDPV2) in environmental samples\u2013 the United Kingdom of Great Britain and Northern Ireland and the United States of America. https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2022-DON408 (2022)."},{"key":"39094_CR5","unstructured":"World Health Organisation (WHO). Circulating Vaccine-derived Poliovirus Type 3 \u2013 Israel (WHO, 2022)."},{"key":"39094_CR6","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.15585\/mmwr.mm7136a2","volume":"71","author":"N Yao","year":"2022","unstructured":"Yao, N. et al. Detection of a highly divergent type 3 vaccine-derived poliovirus in a child with a severe primary immunodeficiency disorder \u2014 Chongqing, China, 2022. Morb. Mortal. Wkly Rep. 71, 1148\u20131150 (2022).","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"39094_CR7","doi-asserted-by":"publisher","first-page":"913","DOI":"10.15585\/mmwr.mm6928a4","volume":"69","author":"G Macklin","year":"2020","unstructured":"Macklin, G. et al. Update on immunodeficiency-associated vaccine-derived polioviruses \u2014 worldwide, July 2018\u2013December 2019. Morb. Mortal. Wkly Rep. 69, 913\u2013917 (2020).","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"39094_CR8","doi-asserted-by":"crossref","unstructured":"Macklin, G. et al. Prolonged excretion of poliovirus among individuals with primary immunodeficiency disorder: an analysis of the World Health Organization Registry. Front. Immunol. 8. http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01103\/full (2017).","DOI":"10.3389\/fimmu.2017.01103"},{"key":"39094_CR9","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.3201\/eid2511.190540","volume":"25","author":"M Shaghaghi","year":"2019","unstructured":"Shaghaghi, M. et al. Vaccine-derived poliovirus infection among patients with primary immunodeficiency and effect of patient screening on disease outcomes, Iran. Emerg. Infect. Dis. 25, 2005\u20132012 (2019).","journal-title":"Emerg. Infect. Dis."},{"key":"39094_CR10","doi-asserted-by":"publisher","first-page":"S368","DOI":"10.1093\/infdis\/jiu065","volume":"210","author":"L Li","year":"2014","unstructured":"Li, L. et al. Poliovirus excretion among persons with primary immune deficiency disorders: summary of a seven-country study series. J. Infect. Dis. 210, S368\u2013S372 (2014).","journal-title":"J. Infect. Dis."},{"key":"39094_CR11","doi-asserted-by":"crossref","unstructured":"Aghamohammadi, A. et al. Patients with primary immunodeficiencies are a reservoir of poliovirus and a risk to polio eradication. Front. Immunol. 8. http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00685\/full (2017).","DOI":"10.3389\/fimmu.2017.00685"},{"key":"39094_CR12","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1186\/s13104-018-3822-7","volume":"11","author":"NM Galal","year":"2018","unstructured":"Galal, N. M. et al. Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians\u2019 perspectives in the endgame plan for polio eradication. BMC Res. Notes 11, 717 (2018).","journal-title":"BMC Res. Notes"},{"key":"39094_CR13","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1111\/j.1365-2672.2006.03020.x","volume":"101","author":"DN Pavlov","year":"2006","unstructured":"Pavlov, D. N. et al. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa. J. Appl. Microbiol.101, 1367\u20131379 (2006).","journal-title":"J. Appl. Microbiol."},{"key":"39094_CR14","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.3201\/eid2310.170724","volume":"23","author":"MC Mohanty","year":"2017","unstructured":"Mohanty, M. C. et al. Poliovirus excretion in children with primary immunodeficiency disorders, India. Emerg. Infect. Dis. 23, 1664\u20131670 (2017).","journal-title":"Emerg. Infect. Dis."},{"key":"39094_CR15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1086\/596052","volume":"199","author":"JP Alexander","year":"2009","unstructured":"Alexander, J. P. et al. Transmission of Imported Vaccine\u2010Derived Poliovirus in an Undervaccinated Community in Minnesota. J. Infect. Dis. 199, 391\u2013397 (2009).","journal-title":"J. Infect. Dis."},{"key":"39094_CR16","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.3201\/eid1411.080517","volume":"14","author":"A Avell\u00f3n","year":"2008","unstructured":"Avell\u00f3n, A. et al. Paralysis case and contact spread of recombinant vaccine\u2013derived poliovirus, Spain. Emerg. Infect. Dis. 14, 1807\u20131809 (2008).","journal-title":"Emerg. Infect. Dis."},{"key":"39094_CR17","doi-asserted-by":"publisher","first-page":"538","DOI":"10.15585\/mmwr.mm7115a2","volume":"71","author":"AL Wilkinson","year":"2022","unstructured":"Wilkinson, A. L. et al. Surveillance to track progress toward polio eradication \u2014 worldwide, 2020\u20132021. Morb. Mortal. Wkly Rep. 71, 538\u2013544 (2022).","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"39094_CR18","doi-asserted-by":"publisher","first-page":"101508","DOI":"10.1016\/j.eclinm.2022.101508","volume":"50","author":"YA Lai","year":"2022","unstructured":"Lai, Y. A., Chen, X., Kunasekaran, M., Rahman, B. & MacIntyre, C. R. Global epidemiology of vaccine-derived poliovirus 2016\u20132021: a descriptive analysis and retrospective case-control study. eClinicalMedicine. 50, 101508 (2022).","journal-title":"eClinicalMedicine."},{"key":"39094_CR19","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.csbj.2017.09.004","volume":"15","author":"K Zhao","year":"2017","unstructured":"Zhao, K. et al. Are circulating type 2 vaccine-derived polioviruses (VDPVs) genetically distinguishable from immunodeficiency-associated VDPVs? Comput. Struct. Biotechnol. J. 15, 456\u2013462 (2017).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"39094_CR20","doi-asserted-by":"crossref","unstructured":"Bandyopadhyay, A. S. & Zipursky, S. A novel tool to eradicate an ancient scourge: the novel oral polio vaccine type 2 story. Lancet Infect. Dis. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473309922005825 (2022).","DOI":"10.1016\/S1473-3099(22)00582-5"},{"key":"39094_CR21","unstructured":"UK Health Security Agency. Expansion of polio sewage surveillance to areas outside London. https:\/\/www.gov.uk\/government\/news\/expansion-of-polio-sewage-surveillance-to-areas-outside-london"},{"key":"39094_CR22","doi-asserted-by":"publisher","first-page":"e045904","DOI":"10.1136\/bmjopen-2020-045904","volume":"11","author":"AS Pethani","year":"2021","unstructured":"Pethani, A. S. et al. Poliovirus excretion among children with primary immune deficiency in Pakistan: a pilot surveillance study protocol. BMJ Open 11, e045904 (2021).","journal-title":"BMJ Open"},{"key":"39094_CR23","unstructured":"Global Polio Eradication Initiative. Global polio surveillance action plan. https:\/\/polioeradication.org\/wp-content\/uploads\/2022\/05\/GPSAP-2022-2024-EN.pdf."},{"key":"39094_CR24","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/j.vaccine.2018.02.059","volume":"36","author":"M Shaghaghi","year":"2018","unstructured":"Shaghaghi, M. et al. New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5 decades of data. Vaccine 36, 1711\u20131719 (2018).","journal-title":"Vaccine"},{"key":"39094_CR25","doi-asserted-by":"publisher","first-page":"38831","DOI":"10.1038\/srep38831","volume":"6","author":"M Bessaud","year":"2016","unstructured":"Bessaud, M., Joffret, M.-L., Blondel, B. & Delpeyroux, F. Exchanges of genomic domains between poliovirus and other cocirculating species C enteroviruses reveal a high degree of plasticity. Sci. Rep. 6, 38831 (2016).","journal-title":"Sci. Rep."},{"key":"39094_CR26","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/s10875-018-0521-z","volume":"38","author":"M Shaghaghi","year":"2018","unstructured":"Shaghaghi, M. et al. Clearing vaccine-derived poliovirus infection following hematopoietic stem cell transplantation: a case report and review of literature. J. Clin. Immunol. 38, 610\u2013616 (2018).","journal-title":"J. Clin. Immunol."},{"key":"39094_CR27","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/S0140-6736(04)16150-3","volume":"363","author":"C MacLennan","year":"2004","unstructured":"MacLennan, C. et al. Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man. Lancet 363, 1509\u20131513 (2004).","journal-title":"Lancet"},{"key":"39094_CR28","doi-asserted-by":"crossref","unstructured":"Kankam, M. K., Burns, J. M., Collett, M. S., Corrado, M. L. & Hincks, J. R. A phase 1 study of the safety, tolerability, and pharmacokinetics of single and multiple oral doses of V-7404 in healthy adult volunteers. Antimicrob. Agents Chemother. 65. https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01029-21 (2021).","DOI":"10.1128\/AAC.01029-21"},{"key":"39094_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/jmv.20533","volume":"78","author":"M Iturriza-G\u00f3mara","year":"2006","unstructured":"Iturriza-G\u00f3mara, M., Megson, B. & Gray, J. Molecular detection and characterization of human enteroviruses directly from clinical samples using RT-PCR and DNA sequencing. J. Med. Virol. 78, 243\u2013253 (2006).","journal-title":"J. Med. Virol."},{"key":"39094_CR30","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1128\/JCM.00542-06","volume":"44","author":"WA Nix","year":"2006","unstructured":"Nix, W. A., Oberste, M. S. & Pallansch, M. A. Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. J. Clin. Microbiol. 44, 2698\u20132704 (2006).","journal-title":"J. Clin. Microbiol."},{"key":"39094_CR31","unstructured":"World Health Organisation (WHO). Polio Laboratory Manual, 4th edn (WHO, Geneva, Switzerland, 2004)."},{"key":"39094_CR32","unstructured":"World Health Organisation (WHO). S1. Supplement to the WHO Polio Laboratory Manual. An alternative test algorithm for poliovirus isolation and characterisation. https:\/\/polioeradication.org\/wp-content\/uploads\/2017\/05\/NewAlgorithmForPoliovirusIsolationSupplement1.pdf."},{"key":"39094_CR33","unstructured":"Global Polio Laboratory Network. Guidance paper 4. Cell authentication testing. 2018 https:\/\/polioeradication.org\/wp-content\/uploads\/2020\/01\/GP4-Cell-Authentication-Testing-Vs1.pdf (2018)."},{"key":"39094_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2017.03.013","volume":"169","author":"A Stern","year":"2017","unstructured":"Stern, A. et al. The evolutionary pathway to virulence of an RNA virus. Cell 169, 35\u201346.e19 (2017).","journal-title":"Cell"},{"key":"39094_CR35","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1093\/infdis\/jix667","volume":"217","author":"M Majumdar","year":"2018","unstructured":"Majumdar, M. et al. Isolation of vaccine-like poliovirus strains in sewage samples from the United Kingdom. J. Infect. Dis. 217, 1222\u20131230 (2018).","journal-title":"J. Infect. Dis."},{"key":"39094_CR36","doi-asserted-by":"crossref","unstructured":"Majumdar, M. et al. Environmental surveillance reveals complex enterovirus circulation patterns in human populations. Open Forum Infect Dis. 5. https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofy250\/5113366 (2018).","DOI":"10.1093\/ofid\/ofy250"},{"key":"39094_CR37","doi-asserted-by":"crossref","unstructured":"Shaw, A. G. et al. Rapid and sensitive direct detection and identification of poliovirus from stool and environmental surveillance samples by use of nanopore sequencing. J. Clin. Microbiol. 58. https:\/\/journals.asm.org\/doi\/10.1128\/JCM.00920-20 (2020).","DOI":"10.1128\/JCM.00920-20"},{"key":"39094_CR38","unstructured":"Tamura, K. & Nei, M. Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol. Biol. Evol. https:\/\/academic.oup.com\/mbe\/article\/10\/3\/512\/1016366\/Estimation-of-the-number-of-nucleotide (1993)."},{"key":"39094_CR39","doi-asserted-by":"crossref","unstructured":"Kumar, S., Stecher, G., Li, M., Knyaz, C., Tamura, K. MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol. Biol. Evol. 35:1547\u20131549. https:\/\/academic.oup.com\/mbe\/article\/35\/6\/1547\/4990887 (2018).","DOI":"10.1093\/molbev\/msy096"},{"key":"39094_CR40","unstructured":"UK Home Office. Code of practice for the housing and care of animals bred, supplied or used for scientific purposes. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/388535\/CoPanimalsWeb.pdf (2014)."},{"key":"39094_CR41","unstructured":"World Health Organisation (WHO). Neurovirulence Test of Types 1, 2 or 3 Live attenuated Poliomyelitis vaccines (Oral) in Transgenic Mice susceptible to Poliovirus (2021)."},{"key":"39094_CR42","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/BF01863914","volume":"162","author":"G K\u00e4rber","year":"1931","unstructured":"K\u00e4rber, G. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Naunyn Schmiedebergs Arch. Exp. Pathol. Pharmakol.162, 480\u2013483 (1931).","journal-title":"Naunyn Schmiedebergs Arch. Exp. Pathol. Pharmakol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-39094-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-39094-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-39094-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T12:06:55Z","timestamp":1686312415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-39094-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,9]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["39094"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-39094-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,9]]},"assertion":[{"value":"9 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3413"}}